Targeted therapy extends survival in cancers of unknown primary microbiologystudy
Progression-free survival in the intention-to-treat population, category 1 patients. Credit: The Lancet (2024). DOI: 10.1016/S0140-6736(24)00814-6 If metastases occur in the […]